Literature DB >> 9337289

Resection of non-small cell lung cancer: how much and by what route.

R J Ginsberg1.   

Abstract

Surgical resection remains the preferred treatment, when possible, in patients with non-small cell lung cancer (NSCLC). A complete resection is required to potentially improve survival of these patients. Lobectomy is the minimum resection of choice. En bloc resections of involved adjacent organs and structures are performed routinely with acceptable morbidity and mortality. Mediastinal lymph node dissection allows accurate surgical and pathologic staging of lymph node disease but has yet to be proven efficacious as a curative procedure. The standard approach to the hemithorax is via posterolateral thoracotomy. Recent muscle-sparing incisions and video-assisted techniques have been employed safely to accomplish goals of surgery. This article evaluates past and current approaches to the resection of NSCLC, and looks at the impact of route and extent of resection on survival of NSCLC patients.

Entities:  

Mesh:

Year:  1997        PMID: 9337289     DOI: 10.1378/chest.112.4_supplement.203s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Approach to Resectable N1 Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database.

Authors:  Chan Y Pu; Sarah Rodwin; Bre Nelson; Najya Fayyaz; Nicholas Scott; Rene J Bouchard; Adrienne Groman; Mark Hennon; Sai Yendamuri
Journal:  J Surg Res       Date:  2020-12-03       Impact factor: 2.417

2.  Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer.

Authors:  Jing Sun; Yong Mao; Yang-Qin Zhang; Yun-DI Guo; Chuan-Yong Mu; Feng-Qing Fu; Xue-Guang Zhang
Journal:  Oncol Lett       Date:  2013-09-13       Impact factor: 2.967

3.  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Kaid Darwiche; Thomas Vogl; Eugene P Goldberg; Haidong Huang; Michael Simoff; Qiang Li; Robert Browning; Francis J Turner; Patrick Le Pivert; Dionysios Spyratos; Konstantinos Zarogoulidis; Seyhan I Celikoglu; Firuz Celikoglu; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-18       Impact factor: 4.162

4.  Lung cancer with chest wall invasion: retrospective analysis comparing en-bloc resection and 'resection in bird cage'.

Authors:  Heron Teixeira Andrade Santos; Agnaldo José Lopes; Cláudio Higa; Rodolfo Acatauassú Nunes; Eduardo Haruo Saito
Journal:  J Cardiothorac Surg       Date:  2014-03-22       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.